Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tap away the pain: new technique may ease injection discomfort

NCT ID NCT07583472

Symptom relief Sponsor: Seyda Can Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether tapping the skin before a shot (the Helfer Skin Tap Technique) can lower pain and boost comfort during a muscle injection. About 60 adults getting a common painkiller injection will be randomly assigned to either the tap method or standard injection. Pain and comfort levels are measured right after the shot to see if the simple tap helps.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals who can speak and understand Turkish, Individuals who are willing to participate in the study and have provided written informed consent, Aged between 18 and 65 years, Body Mass Index (BMI) between 18-24 kg/m², Individuals without sensory-motor deficits, diabetes, peripheral vascular disease, or neuropathy, Individuals who have not received oral or parenteral analgesic treatment before the injection, Individuals without ecchymosis, redness, or swelling at the injection site, Individuals without orthopedic issues preventing internal rotation of extremities, Individuals with intact orientation to time and place, Individuals without visual or hearing impairments. Exclusion Criteria: Individuals who refuse to undergo the technique applied within the study after being enrolled, Individuals who voluntarily withdraw from the study, Individuals for whom less than 24 hours have passed since their last injecti \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain, anxiety, and comfort are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain, anxiety, and comfort

Contacts and locations

Locations

  • Yalova University

    Yalova, Yalova, 77100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.